Clinical Trial Update: Safety and Efficacy of HB-1 for Panic Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of HB-1 for panic disorder completed and results posted, detailing safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• HB-1

Snippet

Sponsor: HB BioTech, LLC | Conditions: Panic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-03-18